Background Surgical site infection (SSI) after total joint arthroplasty (TJA) is a major cause of morbidity. Multiple patient comorbidities have been identified as SSI risk factors including obesity, tobacco use, diabetes, immunosuppression, malnutrition, and coagulopathy. However, the independent effect of multiple individual patient factors on risk of subsequent periprosthetic infection is unclear. Questions/purposes The purposes of this study are (1) to collect data on several preestablished infection risk factors in addition to SSI-related data on a large TJA cohort; and (2) to use multivariate modeling on previously established patient risk factors to determine independent preoperative predictors of SSI.
Introduction
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Infection rates in the TJA population are dependent on intrinsic patient factors [21] . Obesity is a particularly problematic patient risk factor for SSI in the TJA population with a markedly increased risk noted with increasing body mass index (BMI) [6, 21, 23] . Patients with a BMI greater than 50 kg/m 2 reportedly have an 18.3 times higher odds of infection compared with BMI lower than 50 kg/m 2 [21] . Diabetes mellitus is also associated with SSI in patients undergoing arthroplasty [12, 13] , although the degree of attributable risk for infection independent of obesity is difficult to establish [6, 30] . These risks may increase morbidity and mortality while also adding the burden of increased cost [15, 18] . Additional patient risk factors include, but are not limited to, tobacco use, poor dentition, immunosuppression, methicillin-resistant Staphylococcus aureus (MRSA) colonization, malnutrition, inflammatory disease, and coagulopathy [5, 6, 18, 21, 23, 25] .
A major barrier to incorporating SSI risk assessment into clinical practice for joint replacement surgeons is the lack of research assessing the independent effects of multiple patient factors on overall preoperative infection risk. Several studies report multivariate models for SSI risk after TJA, but they include both operative and preoperative variables and therefore have limited use in a preoperative setting [3, 7, 29] . These studies demonstrate that multivariate models are capable of predicting SSI status, but they do not assess whether SSI risk can be adequately determined by preoperative patient risk factors alone. Two studies that focus on preoperative infection risk assessment had mixed results [13, 17] . Lai et al. examined medical comorbidities grouped by organ system and found that diabetes (odds ratio [OR], 3.0; confidence interval [CI], 1.1-14.4; p = 0.041) and genitourinary conditions (OR, 2.87; CI, 0.94-8.0; p = 0.066) were independent SSI risk factors after primary TJA [17] . A major limitation of this grouping strategy is that no distinction is made between diagnoses that may have differing effects on host susceptibility to infection (for example, hepatic cirrhosis versus esophageal reflux). Conversely, Jamsen et al. used a more focused approach and examined obesity, diabetes, and hyperglycemia as [11, 22] Deep wound infection [11, 22] Organ space (periprosthetic infection) [11, 22, 26] [13] . This approach also has its shortcomings, because the performance of their prediction model is limited by only considering a few risk factors. The purposes of this study are (1) to collect data on several established preoperative infection risk factors in addition to SSI-related data on a large TJA cohort; and (2) to use multivariate modeling on previously established patient risk factors to determine independent preoperative predictors of SSI.
Patients and Methods
We retrospectively reviewed all 1875 patients who underwent TJA at our institution from January 1, 2010, to July 30, 2012. The study population consisted of 1640 primary surgeries and 235 revision surgeries. Included joints were limited to the hip, knee, shoulder, and elbow ( Table 2) . A total of 29 (1.5% total; CI, 1.1-2.3; 1.4% primary; CI, 2.0% revision) cases developed SSIs with positive microbial cultures: 15 THAs (11 primary, four revision), 13 TKAs (12 primary, one revision), and one primary total shoulder. Additionally, 4.3% (CI, 3.5-5.4) of patients (29 culturepositive patients and 55 other patients) had an SSI-associated diagnosis within 1 year of TJA. No patients were recalled specifically for this study; all data were obtained from medical records.
Although multiple criteria have been proposed for diagnosing SSI (Table 1) [11, 22, 26] , for the purpose of this study, we required positive microbial cultures for SSI confirmation in addition to the minimum criteria in those studies. Our definitions of superficial incisional and deep incisional infection were consistent with current CDC guidelines [11, 22] . For our definition of organ space infection, we relied on the criteria outlined by Parvizi et al. in the most recent Musculoskeletal Infection Society guidelines [26] . All bacterial isolates were recorded (Table 3 ) in addition to the number of days from the joint arthroplasty until clinical signs of infection.
To identify all patients who potentially met criteria for infection, an International Classification of Diseases, 9 th Revision (ICD-9) code-based query was submitted to the hospital system medical records department. The entire arthroplasty population was first categorized by date of procedure and the associated ICD-9-Clinical Modification procedure code. All patients were then identified who had an ICD-9 diagnosis code assigned within 365 days of the procedure that may be associated with SSI, including codes for osteomyelitis (730.00-730.99), septic arthritis (711.0), SSI (998.3 and 998.5), cellulitis (682), and infection or inflammatory reaction resulting from the joint implant or other hardware (996.66 or 996.67). This search revealed a total of 84 patients who met our initial criteria. We excluded 55 patients because they did not have a total joint infection, leaving a total of 29 infected subjects and 1862 uninfected control subjects.
Patient data were abstracted from the electronic medical record database using a similar query-based protocol. Patient demographic information collected on the same admission as the total joint surgery was obtained in addition to height, weight, and BMI. We then categorized patients by BMI as underweight (BMI \ 18.5 kg/m 2 ), normal (BMI 18.5-24.9 kg/m 2 ), overweight (BMI 25-29.9 kg/m 2 ), obese (BMI 30-39.9 kg/m 2 ), morbidly obese (BMI 40-40.9 kg/m 2 ), or super obese (BMI 50 + kg/m 2 ). All medical diagnoses in the patient's chart before the day of surgery were then reviewed for patient-specific infection risk factors previously reported in the literature, including tobacco use, current or history of bone cancer, diabetes mellitus, hepatitis B or C, HIV, and history of staphylococcus infection or colonization.
Descriptive data were first generated for the entire sample. Of the 29 culture-positive SSIs, we determined the proportion of bacterial isolates (Table 3) . A survival curve was created with data from the 29 culture-positive patients based on time to either SSI confirmation ( Fig. 1 ). We tested BMI for normal distribution using a Kolmogorov-Smirnov goodness-of-fit test, and a receiver operator curve was generated for BMI as a predictor of infection status. For BMI categories (overweight BMI 25.0-29.9 kg/m 2 ; obese BMI 30.0-39.9 kg/m 2 ; morbidly obese BMI 40.0-49.9 kg/m 2 ; and superobese BMI C 50 kg/m 2 ) and all remaining categorical risk factors, a chi-square test was used to test distribution frequency among patients with SSI versus control subjects, and ORs were calculated with 95% CIs. Finally, for all patients who underwent knee, hip, or shoulder TJA (N = 1807), all categorical variables associated with SSI in our descriptive analysis were considered for inclusion in a nominal logistic regression model to predict SSI status. We controlled for operative factors by adjusting for primary versus revision status and site of surgery. We performed all analyses with a statistical software package (JMP 9.0.0; SAS Institute Inc, Cary, NC, USA).
Results
Of the 29 culture-positive infections, superficial infections occurred in eight (28%), deep infections in 10 (34%), and (Table 4 ). Additionally, obesity-related hypoventilation syndrome was more common among patients with SSI (p = 0.01; OR, 10; CI, 1.2-89). No patient with HIV (N = 10, prevalence 0.5%) went on to develop an SSI. After adjusting for operative factors including primary versus revision status (adjusted OR, 2.28; CI, 1.26-3.98; p = 0.005) and anatomic site of surgery (hip or knee versus shoulder, adjusted OR, 2.15; CI, 0.98-5.7; p = 0.057; hip versus knee, p = 0.58), we identified five independent patient risk factors for infection in our nominal logistic regression model (whole model R 2 = 0.10, p \ 0.001, Bayesian information criterion = 633, n = 1807). 
Discussion
Several studies have assessed the independent effect of multiple individual patient factors on preoperative infection risk [3, 7, 13, 17, 29] . Several [3, 7, 29] provide robust multivariate SSI prediction models, but their reliance on both operative and preoperative factors limits their use in a preoperative setting. The few studies that only consider preoperative factors in their risk models either use an overly general strategy for grouping patient comorbidities [17] or only consider a small number of risk factors [13] . Therefore, we have collected data on a larger number of specific, established preoperative infection risk factors in addition to SSI-related data on a large TJA cohort and applied multivariate statistical methods to determine independent preoperative predictors of SSI.
Our retrospective study is subject to a number of limitations. First, like with all medical record reviews, confounding can be introduced by lack of proper documentation. For example, many diagnoses that are relevant to SSI risk or variables such as BMI may not have been adequately documented during hospital encounters for unrelated complaints. This type of confounding will often differentially bias effect sizes toward zero, and we may therefore be underestimating the true effect of our reported risk factors on infection rates. Second, although infection rates and prevalence of bacterial isolates identified in our work are consistent with the literature [9, 32] , we relied on positive cultures for definitive confirmation of SSI, which is not an absolute requirement of current SSI diagnostic criteria [11, 22, 26] . We could not assess for differences in risk factors between culture-negative and -positive SSIs, and our results may therefore not be applicable to culturenegative cases, which may represent as many as 20% of all confirmed infections [28] . Third, 2.1% (39 of 1846) of our healthy control subjects (N = 39) and eight of 29 of our patients with SSI were orthopaedic oncology patients, and therefore our findings might not reflect those from institutions without oncologic practices. Fourth, although the large subset of preestablished infection risk factors considered in our multivariate model allows for a more rigorous adjustment of effect size to determine independent risk than other recent studies (Table 7) , our data set is not exhaustive because our medical diagnosis code-based approach does not allow for consideration of all known infection risk factors.
Our unadjusted analyses agreed with prior reports associating several patient factors, particularly extreme obesity, hepatitis, history of bone cancer, and history of staphylococcus infection or colonization with SSI risk after TJA. Obesity-related data are an important contribution to the surgical infection literature, because obesity itself is overrepresented among patients undergoing arthroplasty. Obesity rates generally decline after age 60 years [8] , yet at least half of patients undergoing TKA and one-third of patients undergoing THA are obese [2, 23] , which is comparable to the current US average adult obesity prevalence of 36% [24] . Our findings regarding obesity are consistent with previous studies noting a markedly increased infection risk at extremes of weight [20, 21, 23, 31, 34] . In particular, it appears that patients who meet the categorical definition of super obesity (BMI [ 50 kg/m 2 ) have a particularly elevated infection risk [21] . Finally, our treatment of BMI as continuous data appeared to be more responsive than categorical definitions for infection risk. In particular, the diagnosis of morbid obesity is often made for any patient with a BMI [ 40 kg/m 2 , but based on our study and previous reports in the arthroplasty literature [21] , a fairly dramatic increase in infection risk occurs well beyond that threshold value. Although categorical definitions are convenient, it may be prudent to move toward describing obesity with a specific BMI in patients with extreme body weight. The high OR reported for current or prior bone malignancy such as sarcoma or metastatic cancer was expected, because the use of megaprosthetics in orthopaedic oncology has been reported to have infection rates of approximately 18% [10] . However, the association between a history of staphylococcus infection or colonization and future infection rates was surprising, because the infection or colonization in many cases was documented as much as 10 years before surgery. This association appeared to be regardless of methicillin resistance, although prior studies have noted a markedly elevated infection risk among MRSA carriers versus methicillin-sensitive S aureus carriers [14] . Finally, the associations of hepatitis, diabetes, and tobacco use with infection are consistent with previous reports [7, 19, 33] .
Our multivariate analysis identifies several independent SSI risk factors and is an important contribution to the TJA literature. An important factor clinicians must consider when comparing risk estimates across studies is how thoroughly the investigators adjusted for concomitant risk factors. (Table 7) [1, 3, 7, 13, 17] . Not only do we establish independent infection risk for multiple patient-specific factors, but we provide adjusted estimates of effect size that will allow clinicians to more readily interpret infection risk in patients with multiple medical conditions. For example, it has been difficult to discern the independent effect of frequently comorbid conditions such as diabetes and obesity on infection risk [7, 30] . We establish that after adjusting for obesity, conditions such as obesity hypoventilation syndrome are nonsignificant risk factors, whereas diabetes mellitus is independently associated with SSI but with a smaller effect size than suggested by unadjusted estimates. Conversely, we establish that the independent association of tobacco abuse on infection rates is very similar to unadjusted rates. Finally, our findings indicate preoperative infection risk assessment based on patient factors may be clinically feasible. Although qualitative clinical algorithms are convenient, the most reliable method of predicting infection risk is to use a quantitative, multivariate formula to capture the additive effect of independent factors on overall infection risk. Our regression model is based on a limited number of previously reported patient risk factors and has moderate to good performance at predicting infection status. However, consideration of a broader number of potential yet unreported SSI risk factors by mining data from existing patient medical records could conceptually produce a more robust prediction model. Further research is indicated in this promising area.
In conclusion, we have created a comprehensive data set of known SSI risk factors and infection outcomes on a large cohort of patients undergoing TJA. We establish comparability of SSI rates, causative organisms, and association of patient factors with infection risk at our institution to data reported in the recent SSI literature. In our multivariate analysis, we establish that several patientspecific risk factors, particularly extreme obesity, prior staphylococcal infection or colonization, hepatitis infection, and current or prior bone cancer, are independently associated with culture-positive SSIs. Our findings allow clinicians to more effectively consider the effect of multiple patient comorbidities on overall infection risk after TJA. Accordingly, preoperative infection risk stratification for patients undergoing TJA may be feasible and should be investigated further.
